Serum proteomic profiling and study of haptoglobin polymorphisms in patients with chronic GVHD after allogeneic hematopoietic stem cell transplantation.

被引：0
|
作者：
McGuirk, Joseph P.
Yan, Ying
Gang, Hao
Hou, Weijian
Abhyankar, Sunil
Williams, Casey
Belt, Robert
Ruan, Jianpa
Yan, Weisi
Wieman, Jeffery
机构：
[1] Kansas City Canc Ctr, Blood & Marrow Transplant Program, Kansas City, MO USA
[2] Univ Missouri, Kansas City, MO 64110 USA
[3] Cornell Univ, Sch Med, Pharmacol Fac Labs, New York, NY 10021 USA
[4] Ctr Canc, New York, NY USA
[5] St Lukes Hosp, Ctr Canc, Kansas City, MO USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2890.2890
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2890
引用
收藏
页码：818A / 818A
页数：1
相关论文
共 50 条
  • [41] The increased elastin degradation in patients treated with allogeneic hematopoietic stem cell transplantation.
    Helbig, G
    Krzemien, S
    BLOOD, 2003, 102 (11) : 410B - 410B
  • [42] Retroperitoneal fibrosis following allogeneic hematopoietic stem cell transplantation - a rare complication of chronic GVHD
    Dicke, C. C.
    Kertesz, A.
    Henke, R-P
    Hasenkamp, J.
    Jung, W.
    Truemper, L.
    Wulf, G.
    ONKOLOGIE, 2012, 35 : 210 - 210
  • [43] Galectin-3 Levels Are Associated with the Incidence and Severity of Chronic GVHD One Year after Allogeneic Hematopoietic Cell Transplantation.
    Navarro-Alvarez, N.
    Andrews, A. R.
    DeFilipp, Z.
    Chen, Y. A.
    Ho, V. T.
    Ritz, J.
    Spitzer, T. R.
    Huang, C. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 638 - 638
  • [44] IFN-γ Induced by PHA Stimulation as New Marker for Gvhd Prediction in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
    Morello, Enrico
    Monsurro, Vladia
    Pagani, Elisabetta
    Cavattoni, Irene
    Coin, Silvia
    Tridente, Giuseppe
    Larcher, Clara
    Cortelazzo, Sergio
    BLOOD, 2008, 112 (11) : 766 - 766
  • [45] Toll like receptors in allogeneic hematopoietic stem cell transplantation.
    Waghmare, AA
    Hubbard, V
    van den Brink, M
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S129 - S129
  • [46] The efficacy and safety of second allogeneic hematopoietic stem cell transplantation.
    Toprak, Selami Kocak
    Korcalo, Ekin
    Seval, Guldane Cengiz
    Bozdag, Sinem Civriz
    Yuksel, Meltem Kurt
    Topcuoglu, Pervin
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Gurman, Gunhan
    Beksac, Meral
    Ilhan, Osman
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Antithymocyte globulin may reduce transplant related mortality and chronic GVHD in patients undergoing allogeneic stem cell transplantation.
    Neumeister, P
    Zinke, W
    Schmidt, HH
    Linkesch, W
    BONE MARROW TRANSPLANTATION, 1999, 23 : S95 - S95
  • [48] T Cell Immunotherapy for Immune Reconstitution and GVHD Prevention After Allogeneic Hematopoietic Stem Cell Transplantation
    Lucarelli B.
    Merli P.
    Strocchio L.
    Cefalo M.G.
    Brescia L.P.
    Locatelli F.
    Current Stem Cell Reports, 2015, 1 (4) : 206 - 214
  • [49] Role of TLR4 In Acute Gvhd After Allogenetic Hematopoietic Stem Cell Transplantation.
    Zhao, Yi
    Liu, Qiuyan
    He, Donghua
    Wang, Lijuan
    Tian, Jun
    Yang, Yang
    Lu, Peilin
    Bao, Hanying
    Li, Yi
    Zheng, Yuanyuan
    Cao, Xuetao
    Cai, Zhen
    BLOOD, 2010, 116 (21) : 1051 - 1051
  • [50] Successful treatment with an induction of GVHD in relapsed ATL after allogeneic hematopoietic stem cell transplantation
    Kamimura, T
    Miyamoto, T
    Kawano, N
    Henzan, H
    Hayashi, S
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 86 - 86
12345